Pfizer recalls children’s Advil over mislabeled dosage information

Pfizer Consumer Healthcare, the drugmaker’s over-the-counter division, is recalling one lot of bubble gum-flavored children’s Advil suspension because of a dosage labeling error, according to USA Today.

Advertisement

The dosage cup provided in the package is marked with teaspoons, while the instructions on the label describe dosage information in milliliters.

A dosage error can result in an overdose, according to the recall alert.

Pfizer is encouraging consumers who purchased this over-the-counter product to visit the store they got it from for a full refund.

More articles on pharmacy:
A patient paid $285 for a $40 drug: Here’s why
HHS Secretary: We have the power to eliminate rebates
Roche’s Genentech to cut 223 jobs in California

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

The Performance Gap Your Pharmacy Training Metrics Can’t See

Monday, August 10
12:00 PM - 1:00 PM CDT

Presenters: Michael Alexander, AudirieDr. Tina Moen, PharmD, Colibri Healthcare

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.